Managing blood pressure control in Asian patients: safety and efficacy of losartan

Tommy Tsang Cheung, Bernard Man Yung Cheung Division of Clinical Pharmacology and Therapeutics, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Abstract: Hypertension is common in Asian populations and is a major cause of cardiovascular diseases. The...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheung TT, Cheung BM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/f27e2f75b1344766a1eeed2c86104713
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f27e2f75b1344766a1eeed2c86104713
record_format dspace
spelling oai:doaj.org-article:f27e2f75b1344766a1eeed2c861047132021-12-02T02:45:55ZManaging blood pressure control in Asian patients: safety and efficacy of losartan1178-1998https://doaj.org/article/f27e2f75b1344766a1eeed2c861047132014-03-01T00:00:00Zhttps://www.dovepress.com/managing-blood-pressure-control-in-asian-patients-safety-and-efficacy--peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Tommy Tsang Cheung, Bernard Man Yung Cheung Division of Clinical Pharmacology and Therapeutics, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Abstract: Hypertension is common in Asian populations and is a major cause of cardiovascular diseases. The prevalence of hypertension is increasing in many Asian countries. The overall prevalence of hypertension in India and the People's Republic of China has been estimated to be 20.6% in men and 22.6% in women. However, the rates of detection, treatment, and control of hypertension remain low in Asia. This reflects a low level of literacy and education, as well as a low level of access to medical care. To overcome these obstacles, strategies targeted at education, promotion, and optimization of medical care, are crucial to achieve target blood pressure control. Angiotensin receptor blockers are one of the first-line treatments for essential hypertension because they confer better cardiovascular outcomes. Losartan has been widely evaluated for the management of hypertension. Although some studies suggested that the blood pressure-lowering effect of losartan is perhaps lower than for other angiotensin receptor blockers, losartan has been demonstrated to be beneficial in terms of renal protection in patients with diabetes, heart failure resulting from either systolic or diastolic dysfunction, and diuretic-induced hyperuricemia. However, most of these data were obtained from Caucasian populations. The efficacy and safety of losartan in Asian populations may be different because of genetic and ethnic variations. Therefore, the efficacy and safety of losartan in Asian patients with hypertension warrant further study. Keywords: hypertension, Asians, losartanCheung TTCheung BMDove Medical PressarticleHypertensionAsiansand LosartanGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 9, Pp 443-450 (2014)
institution DOAJ
collection DOAJ
language EN
topic Hypertension
Asians
and Losartan
Geriatrics
RC952-954.6
spellingShingle Hypertension
Asians
and Losartan
Geriatrics
RC952-954.6
Cheung TT
Cheung BM
Managing blood pressure control in Asian patients: safety and efficacy of losartan
description Tommy Tsang Cheung, Bernard Man Yung Cheung Division of Clinical Pharmacology and Therapeutics, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Abstract: Hypertension is common in Asian populations and is a major cause of cardiovascular diseases. The prevalence of hypertension is increasing in many Asian countries. The overall prevalence of hypertension in India and the People's Republic of China has been estimated to be 20.6% in men and 22.6% in women. However, the rates of detection, treatment, and control of hypertension remain low in Asia. This reflects a low level of literacy and education, as well as a low level of access to medical care. To overcome these obstacles, strategies targeted at education, promotion, and optimization of medical care, are crucial to achieve target blood pressure control. Angiotensin receptor blockers are one of the first-line treatments for essential hypertension because they confer better cardiovascular outcomes. Losartan has been widely evaluated for the management of hypertension. Although some studies suggested that the blood pressure-lowering effect of losartan is perhaps lower than for other angiotensin receptor blockers, losartan has been demonstrated to be beneficial in terms of renal protection in patients with diabetes, heart failure resulting from either systolic or diastolic dysfunction, and diuretic-induced hyperuricemia. However, most of these data were obtained from Caucasian populations. The efficacy and safety of losartan in Asian populations may be different because of genetic and ethnic variations. Therefore, the efficacy and safety of losartan in Asian patients with hypertension warrant further study. Keywords: hypertension, Asians, losartan
format article
author Cheung TT
Cheung BM
author_facet Cheung TT
Cheung BM
author_sort Cheung TT
title Managing blood pressure control in Asian patients: safety and efficacy of losartan
title_short Managing blood pressure control in Asian patients: safety and efficacy of losartan
title_full Managing blood pressure control in Asian patients: safety and efficacy of losartan
title_fullStr Managing blood pressure control in Asian patients: safety and efficacy of losartan
title_full_unstemmed Managing blood pressure control in Asian patients: safety and efficacy of losartan
title_sort managing blood pressure control in asian patients: safety and efficacy of losartan
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/f27e2f75b1344766a1eeed2c86104713
work_keys_str_mv AT cheungtt managingbloodpressurecontrolinasianpatientssafetyandefficacyoflosartan
AT cheungbm managingbloodpressurecontrolinasianpatientssafetyandefficacyoflosartan
_version_ 1718402198693478400